Technology Transfer
The further development of the German position in international competition will be largely determined by how successfully the enormous added value potential of the scientific results from academic research can be commercially applied in the biotechnology industry. Professional technology transfer that has been adapted to the special features of the life science sector has a key function to play in this area.
We would also like to ask you to discuss our invitation with suitable members of staff in your company and to delegate them to relevant working groups. The experts whom you select should contact our office informally as soon as possible.
Working together on content-related issues is essential for the continued maturation and establishment of the German biotech sector. We look forward to interesting cooperation.
Interested member companies can contact us via e-mail info@biodeutschland.org or telephone +49 30 345 05 9330.
Members
Co-ordinator:
Prof. Dr. Horst Domdey,BIOM Biotech Cluster Development GmbH
Dr. Jürgen Walkenhorst, Provendis GmbH
Experts from the following companies:
Dr. Gerald Böhm, BIO-NET LEIPZIG Technologietransfergesellschaft mbH
Arnd Christ, MediGene AG
Dr. André Domin, Technologiepark Heidelberg GmbH
Janine Donath, ipal GmbH
Volker Erb, BioTOP Berlin-Brandenburg
Rebecca Ernst, CureVac GmbH
Dr. Bettina Hädrich, QIAGEN GmbH
Dr. Frauke Hangen, BioRiver Life Science im Rheinland e. V.
Dr. Thomas Hirse, CMS Hasche Sigle
Thomas Kern, KPMG AG
Wolfgang Korek, BioTOP Berlin-Brandenburg
Marcus Lippold, Unternehmensverband Life Sciences Bremen e. V.
Dr. Klaus Maleck, Evotec AG
Dr. Sibilla Nagel, Rittershaus Rechtsanwälte Partnerschaftsgesellschaft
Mattias Nerger, BIO.NRW Cluster Biotechnologie NRW
Gitte Neubauer, Cellzome AG
Dr. Robert Phelps, SuppreMol GmbH
Dr. Hans-Eric Rasmussen-Bonne, Weitnauer Rechtsanwälte
Dr. Tim Reinhard, Osborne Clarke
Dr. Peter Ruile, MorphoSys AG
Ulrike Schulz, ipal GmbH
Antje Strom, KPMG AG
Dr. Klaus Ullrich, BioCentiv GmbH
Dr. Andre van Hall, BioMedizinZentrumDortmund
Dr. Joachim Vogt, Bayerische Patentallianz GmbH
Dr. Rainer Wessel, Cluster für Individualisierte Immunintervention (CI3) e. V.